Related Experiment Video
Updated: Jul 2, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Assessment of lipid dysfunction in patients on maintenance haemodialysis
Ashfaq Altaf1, Abdul Halim, Dilshad Ahmad Khan
1Department of Nephrology, Military Hospital, Rawalpindi. drashfaqamc@yahoo.com
Insights
Patients on maintenance haemodialysis exhibit lower BMI and lipid levels, including total cholesterol and LDL-C, indicating malnutrition and increased cardiovascular risk. These findings highlight the need for nutritional and cardiovascular support in this population.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Clinical Biochemistry
Background:
- Dyslipidemia is a significant cardiovascular disease risk factor in patients undergoing maintenance haemodialysis.
- Both high and low cholesterol levels are linked to increased cardiovascular mortality in haemodialysis patients.
Purpose of the Study:
- To compare lipid profiles and body mass index (BMI) in maintenance haemodialysis patients versus healthy individuals.
- To identify lipid dysfunction prevalence in a Pakistani nephrology unit.
Main Methods:
- A descriptive comparative study included 70 maintenance haemodialysis patients and 70 healthy controls.
- Body mass index (BMI), serum total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) were measured.
- Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedwald equation.
Main Results:
- Maintenance haemodialysis patients had significantly lower BMI (20.07 vs 22.88 kg/m2) and lower TC (3.84 vs 4.65 mmol/L) and LDL-C (2.21 vs 2.93 mmol/L) compared to controls.
- No significant difference was observed in HDL-C or triglycerides between the groups.
- The most common lipid abnormality in haemodialysis patients was low HDL-C (81%), followed by increased Non-HDL-C (23%).
Conclusions:
- Maintenance haemodialysis patients present with significantly low BMI, total cholesterol, LDL-C, and Non-HDL-C.
- These lipid abnormalities suggest malnutrition, inflammation, and accelerated atherosclerosis, contributing to cardiovascular complications.
- The study underscores the complex relationship between lipid profiles and cardiovascular health in haemodialysis patients.
Background:
Dyslipidaemia is a major risk factor of cardiovascular disease in patients on maintenance haemodialysis. Both increased and decreased levels of cholesterol are associated with increased cardiovascular mortality in haemodialysis patients.
Objective:
To assess the lipid dysfunction among patients on maintenance haemodialysis in a nephrology unit at Rawalpindi as compared with healthy individuals.
Methods:
A descriptive comparative study was carried out in a nephrology unit at Rawalpindi, Pakistan. A total of 140 subjects were included consisting of 70 patients on maintenance haemodialysis (MHD) and 70 healthy controls. Body mass index (BMI) was measured according to WHO guidelines. Serum total cholesterol (TC), triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) were assayed on chemistry analyser. Low-density lipoprotein cholesterol (LDL-C) was calculated by Friedwald equation.
Result:
MHD patients had significantly lower BMI, mean (SD) 20.07 (3.66) as compared with the controls 22.88 (3.97) kg/m2 (p < 0.001). The lipid profile among MHD patients and controls are given as mean (SD): (a) Total Cholesterol 3.84 (1.06) vs 4.65 (0.97) (p < 0.001), (b) LDL-C 2.21(0.77) vs 2.93 (0.71) (p < 0.001), (c) HDL-C 0.95 (0.166) vs 0.97 (0.138) (p = NS), (d) Non HDL 2.88 (0.95) vs 3.67 (0.88) (p < 0.0001), (e) Triglycerides 1.68 (1.09) vs 1.69 (0.86) (p = NS). The most common abnormality observed in haemodialysis patients was low HDL-C (81%) followed by increased Non-HDL-C (23%) and increased serum triglycerides (19%).
Conclusion:
It is concluded that our patients on maintenance haemodialysis have significantly low BMI, total Cholesterol, LDL-C and Non-HDL-C depicting malnutrition leading to inflammation, accelerated atherosclerosis process and cardiovascular complications.
Related Concept Videos
Hemodialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Kidney Disease IV: Nursing Management
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease III: Interprofessional Care